Abstract:Objective: Aging on organ level represents the decline of organ function. And the decline of cardiovascular function is associated with the cardiovascular risk. This study is focusing on the prevalence, correlates of healthy organ aging (HOA) and the relationship between cardiovascular risk and HOA. Design and method: This analysis is nested in Northern Shanghai Study (NSS, Clinicaltrials.gov NCT02368938), participants prospectively recruited from June 2014 to June 2017 [n = 2098, 45.52% men, aged 71.3 ± 6.1 years]. To calculate the 10-year Framingham CVD risk, 847 participants aged 65–74 years of age without CVD were finally included in this analysis [40.4% of 2098, 48.76% men, aged 67.9 ± 2.8 years]. Preclinical TODs including left ventricular hypertrophy, left ventricular diastolic dysfunction, micro-albuminuria, CKD, carotid hypertrophy and lower-extremity atherosclerosis were assessed in all the participants. Other clinical information was obtained by standard questionaire. Healthy organ aging was defined as absence of any preclinical TOD. We fitted logistic regression models to assess the cardiovascular risk in association with healthy organ aging. Results: In this analysis, 104 (12.3%) elderly participants had HOA without any preclinical TOD. With the increasing number of TOD, the average 10-year CVD risk increased in both gender. The prevalence of HOA decreased from 17.48% (aged 65–66) to 6.10% (aged over 71). Age, systolic blood pressure, metabolic syndrome and smoking were significantly associated with HOA (p = 0.004 to p < 0.001). After multivariate adjustments, HOA was significantly associated with low CVD risk (<10%) (OR (95%CI), 0.409 (0.260, 0.643), p < 0.001). And the results were stable after stratifying for gender. However, after stratifying for family history of premature CVD, this significance disappeared in the subgroup with family history of premature CVD.Conclusions: Smoking cessation, management of blood pressure and improve metabolic profile may help to delay and prevent organ aging. And HOA is beneficial in terms of the prevention of CVD.

Thyroid Function Decreases with Age and May Contribute to Longevity in Chinese Centenarians’ Families

Oxidative Stress and 4-hydroxy-2-nonenal (4-HNE): Implications in the Pathogenesis and Treatment of Aging-related Diseases

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Alteration of Thyroid Hormones in Mouse Models of Alzheimer’s Disease and Aging

Association of Elevated Thyroid Stimulating Hormone with Atherosclerotic Cardiovascular Disease and Its Mortality in Elderly Community-Dwelling Chinese

Alteration of Thyroid Hormones in Mouse Models of Alzheimer's Disease and Aging.

Views from within and beyond

Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction

Stress and Aging Perspectives. Psychological and Neuro-Psychological Interventions

Decreased oxidative stress response and oxidant detoxification of skin during aging

Targeting NAD+: is it a common strategy to delay heart aging?

Mitochondrial Function in Ageing: Coordination with Signalling and Transcriptional Pathways.

Comprehensive geriatric assessment of elderly highlanders in Qinghai, China, III: oxidative stress and aging in Tibetan and Han elderly highlanders.

Aldehyde Dehydrogenase 2 (ALDH2) and Aging: Is There a Sensible Link?

The role of transient receptor potential ankyrin 1 in age-related endothelial dysfunction.

Longevity and Thyroid Dysfunctions in the Elderly

Views from Within and Beyond: Narratives of Cardiac Contractile Dysfunction under Senescence.

Targeting NAD + Degradation: the Therapeutic Potential of Flavonoids for Alzheimer's Disease and Cognitive Frailty

The Role of Oxidative Stress and Inflammation in Cardiovascular Aging

Vascular Risk Factors and Brain Health in Aging: Insights from a Community-Based Cohort Study

Healthy Organ Ageing Is Associated With Low Cvd Risk In Chinese Elderly: The Northern Shanghai Study